Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2004 | 10-2003 | 10-2002 | 10-2001 | 10-2000 | |
| Sales | 1,228 | 1,298 | 810 | 905 | 1,339 |
| Cost of Goods | 929 | 950 | 446 | 523 | 683 |
| Gross Profit | 299 | 349 | 364 | 382 | 656 |
| Operating Expenses | 335 | 356 | 522 | 745 | 949 |
| Operating Income | -36 | -8 | -158 | -363 | -293 |
| Other Income | 36 | 8 | 158 | 363 | 293 |
| Net Income Continuous | -48 | -43 | -262 | -503 | -314 |
| Net Income | $-48 | $-43 | $-262 | $-503 | $-314 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | -0.03 | -0.02 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | -0.03 | -0.02 |
| EBITDA(a) | $8 | $37 | $-4 | $-154 | $-73 |